Inhalation Sciences Sweden AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
November 22, 2022 at 02:30 am
Inhalation Sciences Sweden AB (publ) reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was SEK 1.78 million compared to SEK 1.14 million a year ago. Net loss was SEK 3.51 million compared to SEK 4.49 million a year ago. Basic loss per share from continuing operations was SEK 0.31 compared to SEK 0.4 a year ago. Diluted loss per share from continuing operations was SEK 0.31.
For the nine months, sales was SEK 8.08 million compared to SEK 5.22 million a year ago. Net loss was SEK 10.98 million compared to SEK 13.53 million a year ago. Basic loss per share from continuing operations was SEK 0.96 compared to SEK 1.2 a year ago. Diluted loss per share from continuing operations was SEK 0.96.